XFOR X4 Pharmaceuticals, Inc.

Fundamentals / CIK 0001501697 / USD

X4 Pharmaceuticals, Inc. reported $9.90M in revenue and a net loss of $80.52M for the trailing twelve months ended September 30, 2026 (up 75.0% year over year), with a 68.8% gross margin and a -812.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open XFOR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$17.09M$8.54M$0-$95.14MFY 2016 Net Income: -$22.98M2016FY 2017 Net Income: -$21.99M2017FY 2018 Revenue: $0FY 2018 Net Income: -$33.28M2018FY 2019 Revenue: $0FY 2019 Net Income: -$52.81M2019FY 2020 Revenue: $3.00MFY 2020 Net Income: -$62.13M2020FY 2021 Revenue: $0FY 2021 Net Income: -$88.70M2021FY 2022 Revenue: $0FY 2022 Net Income: -$93.87M2022FY 2023 Revenue: $0FY 2023 Net Income: -$101.2M2023FY 2024 Revenue: $2.60MFY 2024 Net Income: -$37.45M2024FY 2025 Revenue: $6.50MFY 2025 Net Income: -$79.20M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $6.50M $2.60M $0 $0 $0 $3.00M $0 $0 -- --
Cost of Revenue $5.76M $797K $0 $0 -- -- -- -- -- --
Gross Profit $743K $1.80M $0 $0 -- -- -- -- -- --
Research & Development $72.72M $81.64M $72.02M $61.06M $50.65M $41.93M $30.16M $20.35M $17.07M $17.83M
Total Operating Expenses -- -- $107.5M $87.57M $85.11M $62.87M $51.70M $29.09M $22.25M $24.35M
Operating Income -$86.88M -$36.40M -$107.5M -$87.57M -$85.11M -$59.87M -$51.70M -$29.09M -$22.25M -$24.35M
EBITDA -$85.61M -$35.60M -$107.1M -$87.06M -$84.61M -$59.52M -$51.60M -$28.98M -$22.18M -$24.06M
Interest Income $4.58M $5.77M $4.58M $219K $10K $273K $1.20M $236K $64K --
Interest Expense $8.88M $8.77M $5.78M $3.99M $3.64M $2.69M $2.15M $720K $490K $2.52M
Income Before Tax -$79.16M -$37.14M -$101.1M -$93.84M -$88.68M -$61.98M -$52.81M -$33.28M -$21.99M -$22.98M
Income Tax Expense $41K $310K $78K $28K $17K $148K $0 $0 -- --
Net Income -$79.20M -$37.45M -$101.2M -$93.87M -$88.70M -$62.13M -$52.81M -$33.28M -$21.99M -$22.98M
Basic EPS -$1.87 -$5.59 -$17.07 -$45.65 -$119.82 -$92.79 -$139.04 -$2,376.88 -$1,639.04 -$8,068.66
Diluted EPS -$1.87 -$5.59 -$17.07 -$45.65 -$119.82 -$92.79 -$139.04 -$2,376.88 -$1,639.04 -$8,068.66
Basic Shares Outstanding 42.3M 6.7M 5.9M 2.1M 857.4K 668.6K 383.9K 15.3K 15.3K 2.9K
Diluted Shares Outstanding 42.3M 6.7M 5.9M 2.1M 857.4K 668.6K 383.9K 15.3K 15.3K 2.9K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $2.80M $2.40M $2.50M $2.20M $1.60M $1.70M $900K $1.43M
Cost of Revenue $513K $1.62M $598K $364K $351K $326K $4.72M $302K
Gross Profit $2.29M $783K $1.90M $1.84M $1.25M $1.37M -$3.82M $1.13M
Research & Development $13.34M $15.08M $15.45M $18.52M $17.34M $18.35M $18.51M $21.70M
Operating Income -$19.99M -$16.39M -$20.31M -$23.70M -$27.51M -$26.23M -$9.44M -$35.72M
EBITDA -$19.66M -$15.39M -$20.08M -$23.48M -$27.29M -$25.88M -$8.97M -$35.44M
Interest Income $1.82M $1.98M $2.10M $1.99M $901K $665K $1.02M $1.27M
Interest Expense $2.19M $2.16M $2.13M $2.19M $2.26M $2.23M $2.20M $2.30M
Income Before Tax -$20.20M -$16.16M -$20.24M -$23.93M -$29.84M -$25.70M $316K -$39.56M
Income Tax Expense $3.0K $2.0K $0 $0 -$30K $37K $34K $258K
Net Income -$20.20M -$16.16M -$20.24M -$23.93M -$29.82M -$25.74M $282K -$39.82M
Basic EPS -$0.16 -$0.13 -$0.16 -- -$0.69 -$3.47 $0.04 --
Diluted EPS -$0.16 -$0.13 -$0.16 -- -$0.69 -$3.47 $0.04 --
Basic Shares Outstanding 126.5M 126.3M 126.3M -- 43.3M 7.4M 6.8M --
Diluted Shares Outstanding 126.5M 126.3M 126.3M -- 43.3M 7.4M 6.9M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $217.0M $55.70M $99.22M $121.7M $81.79M $78.71M $126.2M $8.13M $26.68M
Cash & Short-Term Investments $253.0M $102.1M $114.2M $121.7M $81.79M $78.71M $126.2M $8.13M $26.68M
Accounts Receivable, Net $573K $1.07M $0 -- -- -- $0 -- --
Inventory -- $2.82M $0 -- -- -- -- -- --
Other Current Assets -- -- -- -- -- -- -- -- $348K
Total Current Assets $261.6M $112.2M $122.1M $128.7M $87.88M $83.31M $129.3M $9.34M $79.53M
Property, Plant & Equipment, Net $182K $776K $745K $1.10M $1.51M $1.24M $403K $241K $421K
Goodwill $17.35M $17.35M $17.35M $17.35M $17.35M $27.11M $27.11M $0 --
Intangible Assets $9.25M $10.00M $0 -- -- -- -- -- --
Other Non-Current Assets $692K $2.08M $1.44M $1.23M $1.72M $3.26M $1.95M $364K $948K
Total Non-Current Assets $28.88M $34.27M $25.18M $26.91M $29.30M $39.56M $31.42M $605K $1.72M
Total Assets $290.5M $146.4M $147.3M $155.6M $117.2M $122.9M $160.7M $9.94M $81.25M
Accounts Payable $5.70M $8.62M $8.95M $7.78M $4.28M $3.14M $2.09M $2.97M $1.89M
Short-Term Debt -- -- $0 $1.31M $795K $0 $0 $1.69M --
Deferred Revenue (Current) $464K $0 -- -- -- -- -- -- --
Total Current Liabilities $25.76M $32.88M $22.86M $22.32M $14.02M $11.95M $9.45M $7.91M $10.68M
Long-Term Debt $75.00M $75.00M $54.57M $32.30M $33.14M $33.18M $20.00M $8.31M --
Deferred Revenue (Non-Current) $621K $0 -- -- -- -- -- -- --
Other Non-Current Liabilities $525K $831K $432K $173K $826K $462K $16K $205K $9.0K
Total Non-Current Liabilities $78.41M $91.42M $73.30M $59.21M $38.74M $38.12M $22.03M $13.71M $11.87M
Total Liabilities $104.2M $124.3M $96.16M $81.53M $52.76M $50.07M $31.48M $21.62M $22.55M
Total Debt (incl. Leases) $75.99M $77.66M $58.28M $37.10M $38.99M $38.45M $22.82M $10.00M --
Common Stock $91K $6.0K $167K $122K $28K $16K $16K $0 $15K
Retained Earnings -$594.6M -$515.4M -$477.9M -$376.7M -$282.9M -$194.2M -$132.0M -$79.24M -$92.27M
Accumulated Other Comp. Income -$109K -$122K -$119K -$119K -$119K -$119K -$119K $0 $127K
Total Stockholders' Equity $186.3M $22.15M $51.10M $74.05M $64.41M $72.80M $129.2M -$77.09M -$44.55M
Total Equity $186.3M $22.15M $51.10M $74.05M $64.41M $72.80M $129.2M -$77.09M -$44.55M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $185.8M $195.1M $216.9M $217.0M $69.63M $39.22M $40.26M $55.70M
Cash & Short-Term Investments $187.7M $208.0M $233.7M $253.0M $122.2M $63.00M $87.00M $102.1M
Accounts Receivable, Net $1.47M $2.05M $1.11M $573K $891K $1.15M $509K $1.07M
Inventory -- -- -- -- -- -- -- $2.82M
Total Current Assets $198.1M $218.9M $242.0M $261.6M $132.8M $72.94M $95.70M $112.2M
Property, Plant & Equipment, Net $57K $111K $146K $182K $218K $254K $487K $776K
Goodwill $17.35M $17.35M $17.35M $17.35M $17.35M $17.35M $17.35M $17.35M
Intangible Assets $12.82M $13.10M $9.06M $9.25M $9.44M $9.62M $9.81M $10.00M
Other Non-Current Assets $3.19M $2.99M $704K $692K $1.97M $2.35M $3.01M $2.08M
Total Non-Current Assets $33.68M $34.21M $28.30M $28.88M $30.75M $32.23M $34.32M $34.27M
Total Assets $231.8M $253.1M $270.3M $290.5M $163.6M $105.2M $130.0M $146.4M
Accounts Payable $4.88M $3.93M $5.07M $5.70M $5.05M $7.71M $11.12M $8.62M
Deferred Revenue (Current) $938K $842K $910K $464K $592K $754K $855K $0
Total Current Liabilities $14.98M $19.37M $23.77M $25.76M $23.51M $22.90M $25.88M $32.88M
Long-Term Debt $75.00M $75.00M $75.00M $75.00M $75.00M $75.00M $75.00M $75.00M
Deferred Revenue (Non-Current) $391K $592K $117K $621K $789K $827K $955K $0
Other Non-Current Liabilities $522K $523K $526K $525K $525K $535K $567K $831K
Total Non-Current Liabilities $77.95M $78.24M $78.06M $78.41M $78.43M $78.30M $81.19M $91.42M
Total Liabilities $92.93M $97.61M $101.8M $104.2M $101.9M $101.2M $107.1M $124.3M
Total Debt (incl. Leases) $75.19M $75.47M $75.73M $75.99M $76.30M $77.18M $77.41M $77.66M
Common Stock $101K $96K $94K $91K $25K $8.0K $6.0K $6.0K
Retained Earnings -$651.1M -$631.0M -$614.8M -$594.6M -$570.6M -$540.8M -$515.1M -$515.4M
Accumulated Other Comp. Income $0 -$123K -$122K -$109K -$118K -$138K -$128K -$122K
Total Stockholders' Equity $138.9M $155.5M $168.4M $186.3M $61.62M $3.97M $22.94M $22.15M
Total Equity $138.9M $155.5M $168.4M $186.3M $61.62M $3.97M $22.94M $22.15M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$79.20M -$37.45M -$101.2M -$93.87M -$88.70M -$62.13M -$52.81M -$33.28M -$21.99M -$22.98M
Depreciation & Amortization $1.28M $796K $419K $513K $499K $351K $103K $103K $71K $285K
Stock-Based Compensation $4.30M $8.20M $8.69M $5.20M $6.18M $5.43M $2.05M $759K $492K $644K
Change in Receivables $497K -$1.07M $0 $0 -- -- -- -- -- --
Change in Inventory -$1.66M -$2.82M $0 $0 -- -- -- -- -- --
Change in Payables -$2.98M -$286K $1.23M $3.42M $1.17M $1.03M -$2.75M $1.31M -$1.17M $1.26M
Operating Cash Flow -$85.62M -$130.9M -$96.51M -$77.10M -$70.91M -$58.82M -$48.05M -$25.42M -$21.31M -$21.64M
Capital Expenditure $0 -$326K -$60K -$103K -$615K -$1.36M -$174K $0 -$378K -$73K
Free Cash Flow -$85.62M -$131.2M -$96.57M -$77.20M -$71.52M -$60.18M -$48.23M -$25.42M -$21.69M -$21.71M
Purchases of Investments -$63.39M -$57.13M -$16.82M $0 $0 -- -- -- -- --
Investing Cash Flow $8.15M $66.99M -$14.88M -$103K -$615K -$1.36M $27.23M $0 -$378K -$73K
Common Stock Issued $238.5M $0 $60.00M -- -- -- -- -- -- --
Share Repurchases -- -- $0 $0 -$2.00M $0 $0 -- -- --
Financing Cash Flow $238.6M $20.29M $88.52M $117.2M $74.25M $12.39M $140.7M $6.87M $33.42M $18.15M
Net Change in Cash $161.4M -$43.77M -$22.78M $39.92M $2.41M -$47.38M $119.6M -$18.55M $11.73M -$3.67M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$20.20M -$16.16M -$20.24M -$23.93M -$29.82M -$25.74M $282K -$39.82M
Depreciation & Amortization $331K $997K $223K $223K $223K $355K $476K $273K
Stock-Based Compensation $3.50M $3.09M $2.41M $2.27M $760K $748K $519K $2.22M
Change in Receivables $578K -$934K -$541K $318K $254K -$636K $561K -$1.07M
Change in Inventory -$5.0K -$865K -$158K -$399K -$910K -$81K -$272K -$372K
Change in Payables $949K -$1.14M -$624K $642K -$2.65M -$3.44M $2.48M $78K
Operating Cash Flow -$20.19M -$20.79M -$19.60M -$15.53M -$27.82M -$29.90M -$12.37M -$32.99M
Capital Expenditure -- -- -- $0 $0 $0 $0 -$41K
Free Cash Flow -- -- -- -$15.53M -$27.82M -$29.90M -$12.37M -$33.04M
Purchases of Investments $0 $0 $0 -$1.90M -$44.53M -$5.07M -$11.89M -$22.78M
Investing Cash Flow $11.00M -$1.00M $19.25M $16.85M -$28.67M $23.11M -$3.14M -$8.62M
Financing Cash Flow -$112K $75K $2.0K $146.1M $86.91M $5.63M $0 $135K
Net Change in Cash -$9.29M -$21.72M -$365K $147.4M $30.41M -$1.02M -$15.43M -$41.73M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 11.4% 69.3% -- -- -- -- -- -- -- --
Operating Margin -1336.7% -1400.0% -- -- -- -1995.8% -- -- -- --
Net Profit Margin -1218.4% -1440.4% -- -- -- -2071.0% -- -- -- --
Return on Equity (ROE) -42.5% -169.1% -198.0% -126.8% -137.7% -85.3% -40.9% -- -- --
Return on Assets (ROA) -27.3% -25.6% -68.7% -60.3% -75.7% -50.6% -32.9% -334.7% -27.1% --
Current Ratio 10.16x 3.41x 5.34x 5.76x 6.27x 6.97x 13.68x 1.18x 7.45x --
Quick Ratio 9.84x 3.33x 5.34x 5.45x 5.83x 6.59x 13.36x 1.03x 2.50x --
Debt to Equity 0.41x 3.51x 1.14x 0.50x 0.61x 0.53x 0.18x -- -- --
Revenue Growth (YoY) +150.0% -- -- -- -100.0% -- -- -- -- --
Gross Profit Growth (YoY) -58.8% -- -- -- -- -- -- -- -- --
5Y Revenue / Share Growth -96.6% -- -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 68.8% 66.3% 79.5% 10.0% -1.1% -21.3% -59.5% 68.8%
Operating Margin -812.0% -1010.4% -1221.8% -1357.5% -1755.4% -2305.0% -247.5% -1423.6%
Net Profit Margin -813.3% -1036.1% -1246.5% -1237.5% -1687.9% -2219.8% 422.3% -1464.6%
Return on Equity (ROE) -58.0% -58.0% -59.2% -42.5% -154.3% -2568.0% 63.6% -169.1%
Return on Assets (ROA) -34.7% -35.6% -36.9% -27.3% -58.1% -97.0% 11.2% -25.6%
Current Ratio 13.22x 11.30x 10.18x 10.16x 5.65x 3.19x 3.70x 3.41x
Quick Ratio 12.62x 10.85x 9.88x 9.84x 5.24x 2.80x 3.38x 3.33x
Debt to Equity 0.54x 0.49x 0.45x 0.41x 1.24x 19.44x 3.37x 3.51x
Revenue Growth (YoY) +75.0% +41.2% +177.8% +53.4% +185.7% +202.0% -- --
Gross Profit Growth (YoY) +83.1% -43.0% -- +62.2% +275.1% +365.8% -- --
Operating Income Growth (YoY) -- -- -- -- -- -136.9% -- --
Net Income Growth (YoY) -- -- -7277.7% -- -- -128.3% -- --
EPS Growth (YoY) -- -- -500.0% -- -- -125.5% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001501697) · from December 31, 2016 Data through September 30, 2026 · synced Nov 20, 2026, 05:39 UTC · Open in terminal